VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
-8.23%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$351M
AUM Growth
+$351M
(-22%)
Cap. Flow
-$14.4M
Cap. Flow
% of AUM
-4.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
3
Closed
1
Top Buys
| 1 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$3.1M |
Top Sells
| 1 |
CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
|
$11.7M |
| 2 |
Harmony Biosciences
HRMY
|
$4.67M |
| 3 |
ELEV
Elevation Oncology
ELEV
|
$1.04M |
| 4 |
Pharvaris
PHVS
|
$41.1K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ALX Oncology
ALXO
$62.7M
| $78.5M | 22.34% | 9,699,925 | – | – |
|
|
2
Harmony Biosciences
HRMY
$2.12B
| $70.7M | 20.12% | 1,448,720 -95,764 | -6% | -$4.67M |
|
3
Ventyx Biosciences
VTYX
$171M
| $61.3M | 17.45% | 5,011,536 | – | – |
|
|
4
Pharvaris
PHVS
$1.39B
| $50.9M | 14.48% | 2,301,451 -1,859 | -0.1% | -$41.1K |
|
|
CINC
5
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $40.4M | 11.51% | 2,145,035 +164,329 | +8% | +$3.1M |
|
|
IMPL
6
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $25.7M | 7.32% | 2,759,791 | – | – |
|
7
Akero Therapeutics
AKRO
$3.74B
| $20.5M | 5.84% | 2,171,664 | – | – |
|
|
ELEV
8
DELISTED
Elevation Oncology
ELEV
| $2.61M | 0.74% | 1,866,339 -741,828 | -28% | -$1.04M |
|
|
VRNA
9
Verona Pharma
VRNA
$9.16B
| $678K | 0.19% | 161,897 | – | – |
|
|
CMPI
10
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| – | – | -3,673,374 | Closed | -$11.7M |
|